Company intelligence / Profile preview

JBS

Not specified, Pennsylvania or unspecified PA location [incorporated], United Statesjbs-science.com ↗

Ownership: Private
Development stage: Commercial

Overview

JBS Science develops proprietary technologies for isolating cell-free DNA from urine and blood, enabling highly sensitive qPCR assays for tumor DNA markers. Their approach aims to transform noninvasive cancer screening, recurrence monitoring, and personalized oncology care. The company collaborates with leading biomarker researchers and clinical specialists. Recent milestones include scientific advisory board expansion and accepted abstracts at major oncology conferences such as ASCO.

Therapeutic areas: Oncology
Modalities: Diagnostic assay (qPCR-based)Liquid biopsy technology
Industry: Molecular Diagnostics

Partnerships

Collaborations with leaders in biomarker research and clinical specialists; specific partners not named.

Beyond the preview

Go deeper on JBS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JBS.